In vitro anti-microbial and DNA cleavage studies of benzimidazole derivatives
ABSTRACT:
The increase in bacterial
resistance has attracted considerable interest in the discovery and development
of new classes of antibacterial agents. The new agents should preferably
consist of chemical characteristics that clearly differ from those of existing
agents. Benzimidazoles are remarkably effective compounds both with respect to
their bacteria inhibitory activity and their favorable selectivity ratio.
Extensive biochemical and pharmacological studies have confirmed that these
molecules are effective against various strains of microorganisms. Some
benzimidazole compounds inhibit the biosynthesis of ergosterol, required in the
cell membrane of fungi. They have antibacterial, antifungal, and antiviral
activity. This ring system is present in numerous antiparasitic and antitumoral
drugs. The benzimidazole structure is part of the nucleotide portion of
vitamine B12 and the nucleus of some drugs, such as proton pump inhibitors and
anthelmintic agents. Proton pump inhibitors (PPIs) are substituted benzimidazole
derivatives that selectively and irreversibly inhibit the gastric
hydrogen–potassium adenosine triphosphatase (H+K + -ATPase) pump mechanism. The
antimicrobial activity of this class of compounds was investigated against
Helicobacter pylori[10] and against oral streptococci. Also, benzimidazole and
its derivatives are of considerable importance because of their antihistaminic,
cytostatic, local analgesic, hypotensive and anti-inflammatory activity.
Benzimidazole was confirmed to have moderate in vitro anti-HIV effect.
For more details Home Page URL: http://www.jocpr.com/
For more details PDF Link: http://www.jocpr.com/articles/in-vitro-antimicrobial-and-dna-cleavage-studies-of-benzimidazole-derivatives.pdf
Comments
Post a Comment